AbbVie Contract Manufacturing has a portfolio of state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. For more than 30 years, AbbVie Contract Manufacturing has offered contract manufacturing services that spans biologics, potent, drug product, prefilled syringes, fermentation, as well as selling high quality
active pharmaceutical ingredients (APIs).
Shanghai Acebright Pharmaceuticals Group Co Ltd was founded in 1996. More than 12 GMP standard manufacturing sites located in China and India. Focus on a serial of Vitamin products, ARV APIs & intermediates, and oncology APIs & FPPs, etc. Integrated CDMO service partner from R&D to commercial manufacturing.
Pharmaceutical and Cosmetics manufacturing ADELCO is one of the oldest and most respected pharmaceutical company in Greece , established in 1934 for the manufacture of pharmaceuticals and toiletry cosmetics. The company produces annually about two million pcs of about fifty pharmaceutical items, branded generics and unique combinations in a variety of forms Tablets, Syrups, Creams, capsules etc, with emphasis on Neurological and Cardiological preparations and Folic Acid. Many of which are leaders in the market. The company is located on its own modern private production facilities of about 10.000 m2 supervised in accordance to European GMP
SIO manufactures pharmaceutical
grade oils (such as olive, soybean, sesame, sunflower, rapeseed oils, etc.)
used both as APIs and as excipients for oil-soluble drug. We offer also an
extensive range of highly purified injectable-grade oils from vegetable origin
that are supported by DMFs. Our solutions meet all relevant pharmaceutical
regulations and are manufactured according to pharmaceutical cGMP standards.
In addition, SIO offers contract manufacturing capabilities with cGMP production capacity and laboratories audited by the FDA.
For more information on SIO's product offerings and operations please consult www.admsio.com.
AGC Chemicals belongs to AGC Inc., a world-leading producer of glass, chemicals, electronic materials and ceramics. AGC Chemicals is a fluorine specialist, active in CDMO custom chemical synthesis & the production and development of APIs & intermediates, all in compliance with GMP. Continuous improvement is key within AGC.
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization, with sites in Wetteren and Balen, Belgium and San Diego, California, USA, providing comprehensive process development services, cGMP manufacturing and drug product fill finish services of small molecule and biologic APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities to rapidly scale from clinical and pilot programs to commercial quantities, including: Corynex technologies, oglionucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client's needs. Large Molecule Manufacturing: One of the industry's top leaders in microbial biologic manufacturing, using patented technologies and providing impeccable quality. Highly Potent & ADC Services: Ajinomoto Bio-Pharma Services offers dedicated production and laboratory suites for high containment ADC bioconjugates and highly potent compounds, as well as formulation and fill finish services Oligo & Peptide Synthesis: An industry leader in the synthesis of high quality, scalable, custom oligonucleotides and peptides Drug Product Manufacturing: A leader in aseptic filling, offering a wide range of capabilities for vials and syringes Development Services: Our highly knowledgeable Process Development team will establish and characterize a robust manufacturing process to ensure consistent cGMP manufacturing performance Product Quality & Analytical Services: Our well-designed product quality and analytical programs work to ensure the success of your small and large molecule products through th
Alcami is a world-class fully-integrated end-to-end contract development and manufacturing organization (CDMO) headquartered in North Carolina, with executive offices in Durham and Wilmington. With approximately 1,000 employees operating at ten global locations, Alcami provides customizable and innovative services to small and mid-size pharmaceutical and biotechnology companies by offering individualized and integrated services across multiple areas. We connect our clients with innovative solutions for API development and manufacturing, solid-state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services. For more information, please visit alcaminow.com.
About Almac Group
‘Partnering to Advance Human Health'
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown for 50 years and now employs in excess of 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
Shanghai ChemSpec Corporation is the foremost manufacturer of specialty and fine chemicals for Fluorinated Organic compounds in China. Our high quality products serve widely the major markets of Pharmaceutical, Electronic and Agrochemical industries in North America, Europe and Japan. We offer our customers key intermediates and products, and the ability to further grow in an increasingly demanding world. Our efficient customer manufacturing capabilities, ranging from kilograms to full commercial quantity, provide you a reliable and cost effective resources for developing successful businesses.
Amoli Organics Pvt. Ltd., India Is a leading pharmaceutical manufacturer and exporter of API's & Intermediates established 25 years ago. Amoli has 2 manufacturing sites approved by WHO GMP, USFDA, EDQM/EU GMP , PMDA(Japan), TGA (Australia), ANVISA(Brazil) and COFEPRIS(Mexico). We offer APIs covering Anti- Inflammatory, Anti-Hyperlipidemic , Anti- Depressant,Anti-Diabetic, Anti-Convulsant , Anti- Fungal & Vitamin API's. Our key products are Diclofenac Salts, Atorvastatin Calcium and Rosuvastatin. Company's R&D center spread over 12000 sq ft. is engaged in developing in-house process technology for APIs. Amoli's APIs have excellent acceptability globally. Amoli has good presence in more than 85 countries including India.
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI's team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We've got it down to an exact science. We care about the quality and success of your projects as if they were our own. No matter the size of your project or the complexity of the challenge, our experts pinpoint and execute the precise solution to hit your target. From molecule to molecule, batch to batch, your product will benefit from our ingenuity.
Angelini Fine Chemicals division is one of the major CDMO serving the pharmaceutical market. For over 50 years Angelini is recognized in the global pharmaceutical outsourcing market for custom synthesis. Angelini Fine Chemicals is housing cutting-edge R&D flow labs, Class C (10,000) Kilo Lab and industrial micro-reactors for small molecules research, development and commercial manufacturing in custom business.
APIRx Pharmaceuticals B.V. is a leading pharmaceutical company dedicated to manufacturing of natural cannabinoid API's (Active Pharmaceutical Ingredients), which are extracted from cannabis plant material and purified to pharma grade. All manufacturing stages are performed under cGMP conditions. The following cannabinoids are in our product portfolio: Tetrahydrocannabinol (THC or Delta-9THC) Cannabidiol (CBD) Cannabigerol (CBG) APIRx also uses its own API's for the development of new Rx and OTC drugs, nutraceuticals, cosmeceuticals and other products.
We are Ardena, a reputable contract partner delivering drug development, manufacturing, logistics and (bio)analytical services to pharmaceutical customers globally. In parallel, we work with you to compile your regulatory dossier and to fast track your product towards compliance. Every day, we guide companies through the hurdles and challenges of drug development. Our integrated service offering helps to streamline the drug's progress to clinic and beyond. Ardena is your one source contractor for the chemical and pharmaceutical development of your valued compounds. In parallel, we provide you with full product analytical and bioanalytical support during development. Our dossier centric approach makes a difference. We work with you to compile your regulatory dossier in parallel with drug development, saving you time, identifying hurdles and fast tracking your product to compliance. We are experts in writing and formatting supporting CMC documentation.
ATABAY Group of companies: A leader in the production of Paracetamol (Acetaminophen) powder and direct compression grades in its FDA USA-approved and EU, back integrated and dedicated cGMP plant. Back integration covers production of p-aminophenol which is acetylated to Paracetamol and re-crystallized with water as solvent.
Products conform to the current BP, USP, PH EUR pharmacopeias and has COS from EDQM.
Atabay provdies an injectable form of Paracetamol and produces a wide-range of pharmaceutical drugs such as beta-lactam antibiotics, analgesics, antirheumatics, antituberculosis products in tablets, suppositories, syrup, suspension, cream/ointment and sachet dosage forms. Atabay is currently developing generic antiviral drugs with in-house synthesized APIs.
Aurisco is an innovative company dedicated to developing and manufacturing pharmaceutical chemicals serving pharmaceutical companies worldwide. With 2 manufacturing sites for chemistry synthesis & fermentation, all of which are operated according to cGMP standards, Aurisco offers Active Pharmaceutical ingredients (APIs especially in segments of Steroids, Oncology, Anti-Virus and etc.) and drug intermediates as well as contract developing and manufacturing of pharmaceutical chemicals from kilos to tons.
Auro Laboratories Limited is manufacturing generic API's with corporate office located at Mumbai and the manufacturing facility located at Tarapur, Maharashtra, India. We have Certificate of Suitability(COS) for Metformin Hydrochloride and Chlorphenamine Maleate. Manufacturing facility has EUGMP and WHO-GMP certification.API Products manufactured: Metformin Hydrochloride, Glibenclamide, Glimepiride, Glipizide, Chlorphenamine Maleate, Chlorzoxazone.
Avanti Polar Lipids Inc is the world leader for lipids of unparalleled purity. The company manufactures products for the Research Chemist and cGMP lipids for Pharmaceutical Production. These include phospholipids, sphingolipids, detergents, sterols, polymers, bioactive lipids, chelators plus new Fluorescent and Deuterated lipids. Recent developments include unique Detergents, Adjuvants, Glycosylated Sphingolipids and Kdo2 Lipid A - an Endotoxin replacing LPS. Avanti is the licensed manufacturer of mass spectrometry standards to the LIPID MAPS Initiative. Avanti's extensive Lipid Analysis Department handles Identity Testing, Bioanalytical Lipid Assay and cGLP & 21CFR, part 11 Compliant Analysis. Avanti's clients include the Pharmaceutical & Nutraceutical Industries and Lipid Researchers.
Avara offers contract manufacturing of APIs, solid and liquid sterile drug product, and packaging from nine world-class facilities. Led by experienced, entrepreneurial industry leaders, Avara understands clients' individual needs and focuses on providing an exceptional outsourcing experience by delivering on commitments in terms of scope, schedule, compliance and price.
About Bachem Bachem provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Bachem. Pioneering Partner for Peptides
BCN Peptides is focused on the GMP manufacture of synthetic peptides API's for pharmaceutical and veterinary application. We manufacture from R&D to commercial quantities of generic peptides and NCE's. Our state of the heart facility is fully GMP, US FDA and EMEA approved.
Biological E Limited established in 1953, leading manufacturer of Human vaccines Tetanus, DT, DTP, Td HepatitisB, DTP-HepB-Hib Pentavalent, Hib, IPV, Japanese encephalitis, Measles and Rubella, Tetanus Antitoxin and Snake Antivenin. Attained WHO prequalification for Tetanus, DTPHepBHib, JE, DTP and Td. APIs – Noscapine Base and HCL (Alkaloids) and Heparin Sodium. Pipeline Injectables - Heparin Inj, LMWH Enoxaparin, Dalteparin, Fosaprepitant, Daptomycin, Risperidone and Paliperidone Palmitate.
Biophore is a Pharmaceutical Technology Development Center having its operations based in India and also has a registered office in New Jersey, USA. Biophore is a complete R & D organization offering scientific services in Drug Discovery and Process Development for Active Pharmaceuticals for Generics, New Drug Applications and Clinical Trials. Biophore focus is on complex process technologies and is capable of developing manufacturing processes for clinical trials.
BioSpectra – Booth 407: BioSpectra manufactures the highest quality, highest compliant, bulk, GMP Biological Buffers and Denaturants in the only truly dedicated, USFDA registered & inspected, GMP facility. In addition, we offer contract, GMP small molecule synthesis for APIs, Excipients & key Intermediates; Solvent and Solution Compounding and Purification of critical GMP Process Fine Chemicals in small and largescale quantities, exclusively manufactured at our facilities in the USA under full GMP development. We operate 175,000 square feet of privately owned GMP manufacturing and storage space, under the most rigorous quality system, while holding to the most stringent regulatory demands including ICHQ7 and IPEC requirements. With our commitment to quality and compliance, GMP manufacturing that includes synthesis, purification, compounding and compliance support– up through and including Drug Master File submissions, our goal is to become a valued partner in your secure supply chain and the solution to any key ingredient issue you may have.
BioVectra is a contract development and manufacturing organization that serves pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs). An innovative and reliable partner with a strong quality history, BioVectra has over 45 years of experience specializing in:
- Microbial Fermentation
- Complex Chemistry
- High-Potency APIs
- Process & Analytical Development
- Drug Development
We are a global leader with 100 years experience in the research, development and manufacturing of high-grade activated carbon as purification aid in the pharmaceutical and other industries. Our powdered, granular and extruded activated carbons are used for the removal of colors, odors, by-products, traces of catalyst or any other impurities that aren't allowed in the final product. Under the NORIT® brand we produce medicinal products based on activated carbon including contract manufacturing. We meet the most stringent quality requirements that guarantee consistency in performance and purity. Our specialists can support you selecting the best activated carbon for your process in the early drug development phase, scaling up and full production.
Cambridge Isotope Laboratories Inc is the world leader in the manufacture and separation of stable isotopes and stable isotope labeled compounds. CIL offers an array of highly pure compounds that are uniformly or selectively enriched in 13C, 15N, D, 18O or 17O. CIL offers over 15,000 stable-isotope labeled products for use as internal standards and in synthetic applications, including the manufacturing of APIs. CIL maintains one of the only privately held (non-governmental) D2O re-enrichment facilities at our isotope separation facility to further ensure continuous supply of D2O for manufacturing. CIL's capabilities range from milligram to multi-kilogram of deuterated reagents and intermediates. In addition, cGMP suites for manufacturing clinical trial grade materials (CTM) are also available.
BioServices is a global provider of high-quality services in the field of
custom microbial process development and manufacturing. We offer dedicated
solutions for proteins, (high-value) small molecules and microorganisms for
applications in pharma, food, feed and bio-industrial markets.
We are the largest, independent, beta-lactam free microbial contract manufacturing facility in Europe. Our facility is located near Naples, in the south of Italy and has a total fermentation capacity of about 1400 m3 which is spread over two separate fermentation areas. Our associated downstream processing capabilities are spread between multiple, isolated recovery and purification plants with a large diversity of unit operations capable of handling multiple projects in parallel. Recently, we have significantly expanded our spray-drying capabilities, up to pharma API grade.
For more than 50 years, we have built a track record based on our extensive experience in working with a variety of bacterial, yeast and fungal systems. We offer our development and manufacturing services from lab (2-15 L), to pilot (3 m3) to industrial scale (3 m3 - 100 m3).
We have dedicated areas for pharmaceutical manufacturing as well as food-grade manufacturing and comply to cGMP (FDA and EMA approved), GFSI (FSSC 22.000) and ISO standards (14001). Our teams operate on a 24-hour, 7-days/week schedule throughout the year.
Founded in 2001, Caregen is a global leader of research and marketing of Biomimetic Peptides and Growth Factors. Caregen is not only the company to register Growth Factors in PCPC (Personal Care Products Council, formerly CTFA) but also possesses various Biomimetic Peptide patents all around the world. At Caregen, we value innovations and ideas. With highly skilled in-house scientists and marketing specialists with years of experience in developing and manufacturing of innovative active ingredients, we offer a sophisticated line of purified Biomimetic Peptides and Growth Factors at affordable prices, which is made possible from our mass production technology, enabling our current and prospective customers to have the advantages that they always needed. Additionally, we offer customized Biomimetic Peptides and toll manufacturing services that will provide our customers the solution to their research and manufacturing challenges.
Catalyst + Talent
Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing results.
We serve thousands of innovators, large and small, in over 100 markets, including 36 of the top 50 biotech companies and 49 of the top 50 pharmaceutical companies. Our team of over 1,000 talented scientists supports 40% of recent new drug approvals, and our nearly 30 global sites make or package over 100 billion units annually. Our significant intellectual property in oral, injectable, and respiratory dosage forms and advanced drug packaging includes over 1,200 patents and patent applications.
CCPIT Sub-council of Chemical Industry and CCOIC Chemical Industry Chamber of Commerce are the branch organizations of CCPIT and CCOIC. They belong to China Petroleum and Chemical Industry Federation (CPCIF) and work as the CPCIF Conference and Exhibition Department. CCPIT Sub-council of Chemical Industry is a certified member of UFI and Shanghai Convention & Exhibition Industries Association (SCEIA).
We aim to promote trade, economic and technological cooperation between foreign countries and China. Based on serving the entire chemical industry and our member companies, we will make the best efforts to promote the development of chemical industry.
Organizing exhibitions and conferences is our main channel of promoting domestic and overseas economic and trade exchange, however, we organize domestic enterprises to go abroad, hosting and participating in professional chemical industry exhibitions.
Chemi SPA has
relevant expertise in the area of Low Molecular Weight Heparins,
Polysaccharide Derivatives, Peptides and Oncology Products.
Pipeline of several technology-innovative products and generic Finished Dosage Forms with granted Marketing Authorizations and dossiers available for licensing
Chemtrade is the only North American manufacturer of API grade KCl. Our potassium chloride product is supplied globally and is available in Custom morphologies (spheres and cubes) for sustained release or immediate release application. Chemtrade's KCl is currently compliant with USP/EP/FCC/JP/BP and ACS monographs. Chemtrade also manufactures high purity compendial grade (NF/BP/JP/EP/FCC and ACS) KOH and NaOH pellets which are used as excipients for pH adjustment and buffers. Additionally Chemtrade is one of the largest North American manufacturer of aluminum based adjuvants for vaccines and plasma protein separation.
Coral Drugs is an integrated and independent research-based International Pharmaceutical Company that produces a diverse range of high-quality APIs and is headquartered in New Delhi, India. Our API focus covers several therapeutic areas and our facilities are approved by the USFDA, EUGMP and Indian regulatory agencies. At Coral, we believe in maintaining excellent quality standards for our products, services, and quality systems. Our commitment to customers is well-demonstrated by our ability to meet their customized demands and the availability of adequate product documentation such as product DMF's validations, and material/impurity standards. Products include: Active Pharmaceutical Ingredients, API custom manufacturing, Intermediates.
Corbion is a global biochemical ingredient company with a family of proven solutions based on renewable materials and resource-efficient processes that are, above all, safe for people to use and enjoy. Corbion is a new name, but can rely on more than 100 years of experience. We are built on the rich heritage of two successful companies that have been innovator's in the food and biochemical industry: Caravan Ingredients and Purac. We lead the way in sustainable practices through the use of renewable feedstocks and our rich heritage in natural lactic acid.
This forms the foundation for our biochemical applications in everything from (agro)chemicals, to resin adhesives, electronic components, pharmaceuticals, home care, personal care products and animal feed. In manufacturing we have a long history of excellence in sustainable and resource-efficient (fermentation-based) production processes across three key areas: organic acid, polymers, and emulsifiers. We do it, because we believe in the future. At Corbion our purpose is to improve the quality of life for people today and for generations to come. That means inspiring those around us to make a conscious choice in opting for safe, healthy and convenient solutions that benefit people, planet and profit. Afterall, we too are consumers of the product we co-create.We are committed to the biobased business. At Corbion we are looking beyond the here and now,creating ideas, formulas, ingredients and components that go far beyond customer expectations today.We truly believe that asking ourselves, ‘What now?' will lead to ‘What's next?'
Helping our customers solve the big challenges of their customers(the consumer) – is at the center of everything we do. In pharmaceuticals, patients are looking for safe and effective medicines. At Corbion we address these challenges by finding solutions to customers' most difficult questions and enabling them to widen their horizons through a toolbox of high-performance, safe and sustainable products and ingredients.
CordenPharma is your full-service Contract Development & Manufacturing Organization (CDMO) partner for global supply of APIs, Drug Products and Packaging services. Through a network of fully-inspected cGMP facilities across Europe and the US organized under five technology platforms – Peptides, Lipids, & Carbohydrates, Injectables, Highly Potent & Oncology, Small Molecules, and Antibiotics - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products.
Dipharma is one of the leading European manufacturers of Active Pharmaceutical Ingredients, offering about 50 APIs with DMFs lodged worldwide. All three manufacturing sites have been successfully inspected by the European and US Authorities. A fully-equipped R&D Centre, supported by internal Intellectual Property department, develops innovative processes and crystalline forms. One dedicated pilot plant, one small production plant and suitable scale-up facilities make Dipharma the right partner for Custom Synthesis. Core technologies are: Nitration, Nitroesterfication, Complex Hydrogenations, Azidation, Chiral Synthesis, Organometallic, Grignard and Enzimatic chemistry.
Dongkook Pharmaceutical was founded in 1968 and since its foundation, Dongkook has concentrated on R&D and technology innovation. Dongkook is well known for OTC products of high brand values in Korea. Additionally, Dongkook has developed and produced outstanding therapeutic products including anesthetics, contrast media and anti-cancer agents. Dongkook has been recognized by domestic and foreign authorities for its quality of finished products, medical devices and APIs. Currently, Dongkook exports the finished products, medical devices and APIs to over 50 countries around the world, and seeks to grow into a global leading pharmaceutical company.
Enaltec was established in 2006 with the specific objective
to develop and produce niche and technology driven API at competitive prices through
its WHO GMP and US FDA approved sites and supply across the world. Enaltec has further strengthen its foothold in generic formulation
development through its R&D site Enaltec Pharma Research, having capacity to
develop wide range of dosage forms ranging from Solid oral, liquid oral, Derma,
Injectable, Potent molecule (Oncology and Hormones), Undertake cGMP analytical method
validation and registration ICH stability studies at Enaltec Formulation Labs.
ENALTEC= (API R&D + API Manufacturing) + (Formulation R&D [FFS/Turnkey])
Esteve Química has 50 years' experience developing, manufacturing and marketing oral and injectable-non-sterile grade API's (generic and NCE's for third-parties) for regulated markets. Our services include process and analytical development, scale-up, analytical transfer, validation, process optimization and commercial manufacturing, along with any required technical services. We offer particle engineering posibilites (micronization, spray-drying ...). We are regularly inspected by major Health Authorities (USA, Europe, Japan ...). Our cGMP's multipurpose plants (two in Spain (EQ Esteve), one in Mexico (Sintenovo) and one in China (EHP) have a total capacity in excess of 875m3 and clean room areas for the last steps of manufacturing.
Everlight Chemical Industrial Co. founded in 1972 started to develop prostaglandin APIs in 1992. We achieved sustainable growth by balancing economical, social and environmental responsibility and worker's safety. Our APIs have registered worldwidely, including US, Canada, UK, EU, Japan, China, Russia, India, South America, Egypt, Middle East etc. Our plant is certified by Taiwan FDA, US FDA, EMEA, PMDA, Swedish MPA. To date, our sales are widely distributed over 40 countries in the world.
Evonik Industries provides solutions to the pharmaceutical and biopharmaceutical industry for tomorrow's needs in drug development, manufacturing and drug delivery. As a leading speciality chemicals manufacturer, it offers the broadest portfolio of know-how, products and services available in the market: From biotechnology based products to custom intermediates, from excipients for drug formulations to drug delivery technologies, we provide expertise, service and technology that create competitive advantages for our customers. For customers manufacturing APIs and intermediates Evonik is a globally leading supplier of heterogeneous catalysts as well as homogeneous metathesis catalysts which all can be tailored to customer needs.
Fareva is a global pharmaceutical and API leading CDMO, with 10.000 employees in 35 sites (Europe, Russia, Turkey, Americas). Fareva offers flexible solutions for analytical and dosage forms development, clinical trials, regulatory services, and manufacturing of liquids, suspensions, semi-solids, solids, high potents, injectables, ophthalmics, aerosols medical devices, food supplements...
API's We care Farmhispania Group: Farmhispania and Rolabo. Core activities PR&D/Custom manufacturing of APIs supporting brand/generic segments. Selected products also offer dossier/FDF. Operate under cGMP, regularly inspected by World Health Authorities. Technologies include: hydrogenation, HPAPI handling capabilities (<30 ng/m3), HPAPI fermentation, large scale preparative chromatography and cryogenic reactions (-80 °C).
FLAMMA is a family owned & run CMO, established in 1950. Based in the Bergamo area (near Milan in Northern Italy), Flamma is an award winning specialty pharmaceutical chemical manufacturer specialized in the cGMP manufacture of APIs, NCEs, RSMs, and advanced intermediates for the pharmaceutical industry. Flamma has particular expertise in high value chiral materials specifically functional amino acid related materials although Flamma is not limited by these chemistries. Flamma also manufactures specialty compounds and advanced intermediates for the nutraceutical and cosmetic industries and has several generic products available. Flamma prides itself in developing and producing compounds classified as APIs and/or finished products for its customers. FLAMMA has three cGMP manufacturing facilities. Both Italian locations (Chignolo & Isso) (capacities of 120 m3 and 130 m3, respectively) are regularly inspected by the FDA and AIFA (the Italian Ministry of Health). Flamma Honkai is located outside of Dalian, China (on the coast of China; ~1 hour flight from Seoul or Beijing, 2 h from Shanghai) and has 200 m3 of capacity. Each site has their own R&D labs. Flamma leverages their 100% self-owned, self-managed facilities in China to deliver results. Flamma reliably supplies materials directly customers and/or they deliver materials (when required) to their cGMP facilities in Italy in order to deliver the customer's compound on-time with the required specifications. Flamma offers cost-effective services to customers looking for a trusted partner within China who will deliver the quality that one expects. As a fully integrated company, Flamma is well positioned to help move compounds quickly along their path taking into consideration all aspects along the course of the project. FLAMMA- The THINKING CDMO/CMO
Fresenius Kabi Austria is a subsidiary of the global healthcare group Fresenius. The Linz plant is the competence center for manufacturing the APIs Lactulose, Hydroxyethyl starch (HES), and Sinistrin. With 40 years of expertise in Lactulose production, highest quality standards and a second Lactulose plant in Italy, we rank among the leading global Lactulose producers. We supply liquid and crystalline Lactulose, as bulk or finished product in various containers and sachets, filled and packed on-site. Our plant also houses the world's largest production of HES, which is mainly used in volume therapy. Our plant is cGMP- and ISO-certified.
Chemical Industries Co Ltd is a leading manufacturer of Active Pharmaceutical
Ingredients, Drug Products, Excipients and Natural Astaxanthin. Our specialized
contract manufacturing offers API synthesis, solid dispersion with our spray
drying technology, etc. Additionally, we offer unique excipients for oral
dosage forms, such as Neusilin, Fujicalin. and F-MELT.
Genovior Biotech Corp. is a vertically integrated contract development and manufacture company, providing following services:
(a) process development of peptide or protein biologics from microbial or human recombinant fermentation processes
(b) formulation development of biological injectables
(c) manufacturing capacities of biologics, lyophilized injectable, and prefilled syringe/cartridge for preclinical, clinical, and commercial uses
Genovior is a dedicated CDMO focusing on providing high quality products at a competitive cost under cGMP and PIC/S for our customers worldwide. Our facilities fully comply with the regulations of FDA, EMA and other agencies, our one-stop services conveniently provide effective and efficient solution and our non-competition policy provides maximum security and protection in IP for our clients.
GENTEC PHARMACEUTICAL GROUP Our main business areas are the manufacture and commercialization of high quality High Potency Active Pharmaceutical Ingredients (HPAPIs) and Active Pharmaceutical Ingredients (APIs). Pharmanoid is our HPAPI division, developing and manufacturing prostaglandins and similar. Our facilities and quality system follow c-GMP and recommended practice on handling compounds with high containment. Our comprehensive approach includes all activities from R&D and analysis to production including chemical synthesis, purification, large scale chromatography, cleaning and waste management. Contention level from R&D until QC. Full regulatory support is given for the product's whole life cycle. Duke Chem develops and manufactures APIs, as well as Advanced Intermediates or Fine Chemicals for the Nutraceutical & Food markets. We also offer Custom and Contract Manufacturing including process development from laboratory to industrial scale.
We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare.
As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization's three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields.
Our product portfolio also includes a range of consumer brands, many of which are household names around the world, including Sensodyne, Aquafresh, Horlicks, Panadol and Tums.
Primary focused on natural ingredients and APIs production, Gnosis has over 20 years of experience in biotech applications with leading positions in innovative processes of selection and isolation of microorganisms, advanced upstream (fermentation) and downstream (purification) techniques, chemical synthesis and semi-synthesis of natural metabolites. The company offers tailor-made industrial manufacturing of intermediates and active ingredients through a strengthened integration between R&D and cGMP manufacturing facilities. With a European manufacturing network dedicated to high quality and proprietary products for pharmaceutical and nutritional applications, Gnosis constantly works to develop and introduce innovative and forefront products to its worldwide customers.
Originally founded in 1948, Hamari Chemicals Ltd has extensive experience in custom manufacturing of APIs and intermediates. Two production facilities allow us to produce from pilot plant scale to commercial scale that is FDA approved and ISO14001 certified. In addition Hamari can assist you in the drug development process by offering c-GMP synthesis during pre-clinical stages as well as providing process optimization, stability studies, process validation, providing FTE services, and assisting in regulatory filings. Our current strength is being able to offer custom peptides and asymmetric chiral building blocks using our own original catalysts.
Our company is a large-scale comprehensive group owning a public stock company (Huadong Medicine Co Ltd), several joint ventures (Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd, Hangzhou MSD Pharmaceutical Co Ltd, Hangzhou Jiuyuan Gene Engineering Co Ltd, Zhejiang Huayi Pharmaceutical Co Ltd and Zhejiang ESTEVE-HUAYI Pharmaceutical Co Ltd) and series of share-holder pharmaceutical and chemical companies.
We are manufacturer for APIs & Intermediates by fermentation, synthesis and Bio-technology, specifically in the area of immunosuppressant and anti-diabetic agents. Our main products include:- Acarbose, Coenzyme Q-10, Cyclosporine, Mycophenolic Acid, Mycophenolate Mofetil, Orlistat, Sirolimus, Tacrolimus, Vancomycin, etc.
HAPILA GmbH provides high-value services to customers covering pharmaceutical companies, Biotech and Fine Chemicals in the development and manufacture of APIs. We are an independent enterprise with long-standing experience in the API value-creation chain: synthesis, purification and particle design; to support the development and manufacture of drug products.
Harman Finochem Limited is a 35 year old company engaged in manufacturing of API's and chemical intermediates having global presence. We have two state of art cGMP complaint facilities meeting latest regulatory standards, inspected by USFDA, EU, PMDA, KFDA, TGA, ANVISA & PIC/s. With forward integration and R&D support, we can offer CRAMS & CMO services for FDFs. Please visit us on: www.harmanfinochem.com
Hikal is a reliable long-term outsourcing partner and supplier of key active ingredients and intermediates to companies in the Pharmaceuticals, Crop Protection and Specialty Chemicals industry. Our advanced manufacturing facilities have been certified by the US FDA, MHRA, EDQM, COFEPRIS,TGA, and are ISO 9001:2008, ISO 14001 and OHSAS 18001 certified. Strengths: Supply and Regulatory support on Generic APIs, Custom Synthesis; Contract manufacturing; Process development and Scale-up expertise; Respect for Intellectual Property. Hikal has five state-of-the-art manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and two in Bangalore (Jigani) including an R&D centre and a state-of-the art R&D center at Pune. Our most recent FDA inspection was in November of 2016 with no 483s.
Hovione is an international company with over 58 years of experience as a Contract Development and Manufacturing Organization (CDMO) and is currently a fully integrated supplier offering services for drug substance, drug product intermediate and drug product. With four FDA inspected sites in the USA, China, Ireland and Portugal and development laboratories in Lisbon, Portugal and New Jersey, USA, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds. Hovione offers a full range of development services and manufacturing capacity in particle engineering (Spray Drying, Spray Congealing, Hot Melt Extrusion, Jet Milling, Nanoparticles and Wet Polishing) to provide optimal solutions for your drug product with the right scale and flexibility. For generic pharmaceutical customers the company offers niche API products. Hovione also provides proprietary product development and licensing opportunities for drug products. In the inhalation area, Hovione is the only independent company offering a complete range of services. Please visit www.hovione.com
HTL SAS was created in 1992 and is specialized in the manufacture, purification and research and development of Hyaluronan (HA). Today it has diversified and produces other biological polymers for the pharmaceutical and medical fields.
ICROM is an Italian chemical-pharmaceutical Company specialized in
contract development and GMP manufacturing of Potent and non-Potent APIs. A
reliable partner with a strong know-how, that is present and active on the
worldwide pharmaceutical market since more than 40 years, and that with passion
and professionalism were able to diversify over the years its business model
and portfolio, strongly investing in research&development and innovative
products. With four state-of-the-art manufacturing units approved by AIFA, USFDA,
PMDA, KFDA and high-quality standards, ICROM is the partner of choice for
custom synthesis, contract manufacturing, niche generics, difficult-to-make